FDA NDC Directory · JSON-LD · Markdown

Glycopyrrolate

NDC 65219-801 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA209328
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsGLYCOPYRROLATE (.2 mg/mL)
Marketing started20231231
Package count1

External sources

Source: openFDA. Public-domain (CC0).